Beit Jala Pharmaceutical Company announced unaudited earnings results for the first quarter ended March 31, 2019. For the quarter, the company reported sales of JOD 1,765,987 against JOD 1,524,137 a year ago. Net income after tax was JOD 133,001 against JOD 82,599 a year ago. Basic and diluted earnings per share were JOD 0.019 against JOD 0.012 a year ago.